We live in an aging society. Medical standards continue to develop and medicine is constantly evolving as scientists carry out research into new drugs. More and more people require medication and cases of polymedication, where people need to take numerous different types of medicine every day, are becoming more common.
A leading mining company in Laos further bolstered its operations with the support of DKSH and Agilent’s mining solutions.
By setting up a new bioavailability and bioequivalence laboratory, a leading testing and research lab was able to deliver better services to the under served generic pharmaceutical industries in the Philippines.
Water activity is a powerful and often essential quality parameter for pharmaceutical products. Benefits of this method are higher quality production output, greater consumer satisfaction and confidence, less product waste and recalls and, consequently, greater profits for the manufacturer.
Compared to drug administration through swallowing, delivery via the lung is much more effective due to the lung’s large surface area, thin membrane, and outstanding blood supply that guarantee fast drug absorption. Contact angle measurements can help develop pulmonary NSAID delivery systems.
Indonesia, with a population of more than 260 million, is currently the largest pharmaceutical market in ASEAN and among the fastest growing in Asia. With over 210 drug manufacturers and 30,000 medicinal plants in the country, this industry will only get larger.
We equipped the University of the Philippines’ new Drugs of Abuse Research Laboratory (DARL) in Manila with the latest drug test kits to help identify more drugs and speed up the availability of test results.
Delivering Growth – in Asia and Beyond.
© DKSH International Ltd.
Please enter your details here:
